NEW YORK, May 5, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX). Such investors are advised to contact Peretz Bronstein or his investor relations analyst Yael Hurwitz at firstname.lastname@example.org or 212-697-6484.
The investigation concerns whether Express Scripts and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On January 12, 2016, Anthem, Inc. openly threatened to cease its relationship with Express Scripts if Express Scripts would not agree to deliver more than $3 billion in annual savings to Anthem. Following this news, Express Scripts dropped $5.89 per share, or 6.88%, to close at $79.69 on January 13, 2016. Then, on March 21, 2016, Anthem charged Express Scripts, claiming that the Company violated its contract with Anthem by failing to negotiate drug pricing terms in good faith. The opening of this lawsuit exposed a battle between Express Scripts and Anthem going back as early as February 2015, and included accusations that Express Scripts had significant operational problems that interfered with its ability to properly serve Anthem and exposed Anthem to additional monitoring. Shareholders also learned that Anthem would be renegotiating its contract to pay billions of dollars less to Express Scripts, or find a competing pharmacy benefit manager, subsequently losing of Anthem's business.
If you are aware of any facts relating to this investigation, or purchased shares of Express Scripts, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/#!esrx/bsz2p. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-express-scripts-holding-company-esrx-300264018.html
SOURCE Bronstein, Gewirtz & Grossman, LLC